Truvestments Capital »

Ovid Therapeutics shares owned by Truvestments Capital

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Truvestments Capital from 13F filings

Historical chart of Truvestments Capital investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Truvestments Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Truvestments Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.6k 1.3k 2.69

More positions owned by Truvestments Capital

NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Corning Incorporated (GLW)
Broadcom (AVGO)
Apple (AAPL)
Caterpillar (CAT)
Applied Materials (AMAT)
Celestica (CLS)
Dell Technologies CL C (DELL)
Qualcomm (QCOM)
Marvell Technology (MRVL)
Ryder System (R)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Johnson & Johnson (JNJ)

View all positions for Truvestments Capital

Top funds holding Ovid Therapeutics

Jupiter Topco
Eventide Asset Management
BlackRock
Henderson Group
RA Capital Management
Affinity Asset Advisors
Vanguard Capital Management
ADAR1 Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Federated Investors
Braidwell
Geode Capital Management
Silverarc Capital Management
Stempoint Capital

View all funds holding Ovid Therapeutics